A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.
Matsushita M, Ozaki Y, Hasegawa Y, Terada F, Tabata N, Shiheido H, Yanagawa H, Oikawa T, Matsuo K, Du W, Yamada T, Hozumi M, Ichikawa D, Hattori Y.
Matsushita M, et al. Among authors: oikawa t.
PLoS One. 2015 Jan 24;10(1):e0116135. doi: 10.1371/journal.pone.0116135. eCollection 2015.
PLoS One. 2015.
PMID: 25617756
Free PMC article.